BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 15353901)

  • 1. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
    Habs M
    Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
    Degenring FH; Suter A; Weber M; Saller R
    Phytomedicine; 2003; 10(5):363-9. PubMed ID: 12833999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Crataegus special extract WS 1442 in the treatment of early stages of CHD-associated heart failure].
    Koller M; Lorenz W; Aubke W; Jensen A; Gerlach FM; Kuhl J; Pfeil T; Regitz-Zagrosek V; Rusche H; Rychlik R
    MMW Fortschr Med; 2006 Feb; 148(6):42. PubMed ID: 16526340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
    Weikl A; Assmus KD; Neukum-Schmidt A; Schmitz J; Zapfe G; Noh HS; Siegrist J
    Fortschr Med; 1996 Aug; 114(24):291-6. PubMed ID: 8974970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-dose Crataegus extract WS 1442 in the treatment of NYHA stage II heart failure].
    Tauchert M; Gildor A; Lipinski J
    Herz; 1999 Oct; 24(6):465-74; discussion 475. PubMed ID: 10546150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review.
    Holubarsch CJF; Colucci WS; Eha J
    Am J Cardiovasc Drugs; 2018 Feb; 18(1):25-36. PubMed ID: 29080984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
    Zapfe jun G
    Phytomedicine; 2001 Jul; 8(4):262-6. PubMed ID: 11515715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
    Rietbrock N; Hamel M; Hempel B; Mitrovic V; Schmidt T; Wolf GK
    Arzneimittelforschung; 2001 Oct; 51(10):793-8. PubMed ID: 11715631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.
    Eggeling T; Regitz-Zagrosek V; Zimmermann A; Burkart M
    Phytomedicine; 2011 Nov; 18(14):1214-9. PubMed ID: 21784624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hawthorn extract for treating chronic heart failure.
    Pittler MH; Guo R; Ernst E
    Cochrane Database Syst Rev; 2008 Jan; (1):CD005312. PubMed ID: 18254076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
    Pittler MH; Schmidt K; Ernst E
    Am J Med; 2003 Jun; 114(8):665-74. PubMed ID: 12798455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crataegus special extract WS 1442: up-to-date review of experimental and clinical experiences.
    Zorniak M; Szydlo B; Krzeminski TF
    J Physiol Pharmacol; 2017 Aug; 68(4):521-526. PubMed ID: 29151068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study].
    Leuchtgens H
    Fortschr Med; 1993 Jul; 111(20-21):352-4. PubMed ID: 8375791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival and prognosis: investigation of Crataegus extract WS 1442 in congestive heart failure (SPICE)--rationale, study design and study protocol.
    Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M
    Eur J Heart Fail; 2000 Dec; 2(4):431-7. PubMed ID: 11113721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse-event profile of Crataegus spp.: a systematic review.
    Daniele C; Mazzanti G; Pittler MH; Ernst E
    Drug Saf; 2006; 29(6):523-35. PubMed ID: 16752934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hawthorn on the progression of heart failure in a rat model of aortic constriction.
    Hwang HS; Boluyt MO; Converso K; Russell MW; Bleske BE
    Pharmacotherapy; 2009 Jun; 29(6):639-48. PubMed ID: 19476417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hawthorn Extract Randomized Blinded Chronic Heart Failure (HERB CHF) trial.
    Zick SM; Vautaw BM; Gillespie B; Aaronson KD
    Eur J Heart Fail; 2009 Oct; 11(10):990-9. PubMed ID: 19789403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health effects of hawthorn.
    Dahmer S; Scott E
    Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
    Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
    Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hawthorn--Crataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn; Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn.
    Rasmussen P
    J Prim Health Care; 2011 Mar; 3(1):63-4. PubMed ID: 21359265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.